Exacerbations of severe asthma in patients treated with mepolizumab-Reference-Cited by-同舟云学术

Exacerbations of severe asthma in patients treated with mepolizumab

Published:2018-11-21 Issue:6 Volume:52 Page:1801127
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Shrimanker Rahul,Pavord Ian D.,Yancey Steve,Heaney Liam G.,Green Ruth H.,Bradding Peter,Hargadon Beverley,Brightling Chris E.,Wardlaw Andrew J.,Haldar Pranabashis

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference8 articles.

1. Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

2. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

3. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies;Ortega;Lancet Respir Med,2016

4. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

5. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo;ERJ Open Research;2024-05-23

2. Tezepelumab in a case of severe asthma exacerbation and influenza-pneumonia on VV-ECMO;Respiratory Medicine Case Reports;2024

3. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma;Tuberk Toraks;2023-03-10

4. Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future;Pharmaceuticals;2023-02-10

5. Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients;Journal of Personalized Medicine;2022-01-07